TINNITUS FORSCHUNGS UND ENTWIC has a total of 16 patent applications. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals are BESINS INT BELGIQUE, SHANGHAI YOUSEEN NEW MEDICINE and TANGENT REPROFILING LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Australia | 3 | |
#3 | Canada | 2 | |
#4 | United States | 2 | |
#5 | Israel | 1 | |
#6 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Fakler Bernd | 11 |
#2 | Ruppersberg J Peter | 10 |
#3 | Busch Andreas | 3 |
#4 | Zenner Hans Peter | 3 |
#5 | Ruppersberg J Peter Prof Dr | 3 |
#6 | Peter Ruppersberg J | 1 |
Publication | Filing date | Title |
---|---|---|
EP1201234A2 | Treatment of diseases with adamantane derivates | |
EP1190711A1 | Treatment of diseases with adamantane derivatives | |
EP1190709A1 | Treatment of tinnitus | |
EP1190708A1 | Medical use of substances | |
IL123142D0 | Use of adamantane derivatives in the preparation of a medicament for the treatment of tinnitus |